In inflammatory bowel disease models including ulcerative colitis and cysteamine-induced colitis, BPC-157 reduces inflammatory markers (IL-6, TNF-, IL-1), improves mucosal architecture, and accelerates healing of damaged intestinal tissue
GLP-1 hinders gallbladder motility and postpones gallbladder evacuation by inhibiting cholecystokinin secretion [40-44]
L.OtsukaH.BhushanS.WangZ.BradleyJ.TrivediR.et al (2016)
For example, approximately 6.3% of people with diabetes worldwide suffer from diabetic foot ulcers (DFUs), and an estimated 8 million people live with chronic wounds that often progress to severe complications such as sepsis or amputation [1]
Sources: Rebouche C.J., Seim H., Carnitine Metabolism and Functions, Annual Review of Nutrition (1998)